ICM
AZN icon

Ionic Capital Management’s AstraZeneca AZN Stock Holding History

Ionic Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,000
Closed -$3.11M – 296
2017
Q1 		$3.11M Buy
+50,000
New +$2.91M 0.19% 140

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ionic Capital Management's AZN Position: Q2 2017 in Review

Ionic Capital Management sold out of AstraZeneca (AZN) in Q2 2017, closing a stake of 2,500 shares — an estimated $156K sold.

Ionic Capital Management first reported a position in AZN in Q1 2017 and held it in 1 quarter. The position peaked at $156K in Q1 2017. 466 funds tracked by Wall St. Rank hold AZN as of Q2 2017.

  • Ionic Capital Management reported no remaining AstraZeneca position as of Q2 2017 after selling out during the quarter.
  • Ionic Capital Management sold 2,500 AstraZeneca shares in Q2 2017, an estimated $156K.
  • Ionic Capital Management first reported a position in AstraZeneca in Q1 2017 and held it in 1 quarter.
  • Ionic Capital Management's AstraZeneca position peaked at $156K in Q1 2017.
  • 466 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2017.

Based on Ionic Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.